Total Payments
$147,583
2024 Payments
$1,776
Companies
19
Transactions
73
Medicare Patients
89
Medicare Billing
$21,052
Payment Breakdown by Category
Consulting$141,000 (95.5%)
Food & Beverage$4,058 (2.7%)
Travel$1,458 (1.0%)
Research$1,046 (0.7%)
Education$21.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $141,000 | 3 | 95.5% |
| Food and Beverage | $4,058 | 66 | 2.7% |
| Travel and Lodging | $1,458 | 1 | 1.0% |
| Unspecified | $1,046 | 2 | 0.7% |
| Education | $21.40 | 1 | 0.0% |
Payments by Type
General
$146,537
71 transactions
Research
$1,046
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OrganOx Ltd | $142,729 | 7 | $0 (2024) |
| Gilead Sciences, Inc. | $1,888 | 20 | $0 (2024) |
| TransMedics, Inc. | $1,046 | 2 | $0 (2019) |
| AbbVie Inc. | $472.23 | 5 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $269.56 | 13 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $259.22 | 3 | $0 (2018) |
| Eisai Inc. | $200.32 | 7 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $162.54 | 2 | $0 (2023) |
| Biocompatibles, Inc. | $124.47 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $111.42 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,776 | 6 | OrganOx Ltd ($1,563) |
| 2023 | $432.47 | 4 | OrganOx Ltd ($166.80) |
| 2022 | $272.81 | 6 | Gilead Sciences, Inc. ($229.31) |
| 2020 | $181.68 | 4 | Gilead Sciences, Inc. ($124.91) |
| 2019 | $25,894 | 16 | OrganOx Ltd ($24,000) |
| 2018 | $41,057 | 16 | OrganOx Ltd ($40,000) |
| 2017 | $77,969 | 21 | OrganOx Ltd ($77,000) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), DIFICID | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $122.24 | General |
| 10/15/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $73.46 | General |
| Category: LIVER DISEASE | ||||||
| 06/06/2024 | OrganOx Ltd | METRA (Device) | Travel and Lodging | Cash or cash equivalent | $1,457.60 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 05/08/2024 | OrganOx Ltd | METRA (Device) | Food and Beverage | Cash or cash equivalent | $30.59 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 04/23/2024 | OrganOx Ltd | METRA (Device) | Food and Beverage | Cash or cash equivalent | $74.37 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 06/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $48.66 | General |
| Category: HCV | ||||||
| 06/04/2023 | OrganOx Ltd | METRA (Device) | Food and Beverage | Cash or cash equivalent | $166.80 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 06/04/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $97.97 | General |
| 11/06/2022 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $41.92 | General |
| Category: HBV | ||||||
| 08/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $117.70 | General |
| 08/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.55 | General |
| 07/30/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.92 | General |
| 07/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.22 | General |
| 03/12/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: VIROLOGY | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Oncology | ||||||
| 01/06/2020 | Gilead Sciences, Inc. | Harvoni (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: HCV | ||||||
| 11/20/2019 | Biocompatibles, Inc. | THERASPHERE-BIO (Device) | Food and Beverage | In-kind items and services | $124.47 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 11/20/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Oncology | ||||||
| 10/28/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Virology | ||||||
| 10/17/2019 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $21.40 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 09/18/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROTECT LIVER | TransMedics, Inc. | $836.48 | 1 |
| LIVER RESEARCH | TransMedics, Inc. | $209.12 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 26 | 59 | $28,954 | $8,832 |
| 2021 | 1 | 21 | 35 | $17,074 | $5,464 |
| 2020 | 2 | 42 | 62 | $23,139 | $6,756 |
Total Patients
89
Total Services
156
Medicare Billing
$21,052
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 59 | $28,954 | $8,832 | 30.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 35 | $17,074 | $5,464 | 32.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 51 | $20,299 | $6,206 | 30.6% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 11 | 11 | $2,840 | $549.81 | 19.4% |
About Angeles Baquerizo
Angeles Baquerizo is a Surgery healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053425330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angeles Baquerizo has received a total of $147,583 in payments from pharmaceutical and medical device companies, with $1,776 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($141,000).
As a Medicare-enrolled provider, Baquerizo has provided services to 89 Medicare beneficiaries, totaling 156 services with total Medicare billing of $21,052. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Transplant Surgery
- Location La Jolla, CA
- Active Since 08/17/2006
- Last Updated 04/22/2014
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1053425330
Products in Payments
- METRA (Device) $1,729
- Harvoni (Drug) $1,122
- Organ Care System (Device) $1,046
- Mavyret (Drug) $449.94
- Nexavar (Drug) $249.43
- Envarsus XR (SP) (Drug) $224.62
- Lenvima (Drug) $200.32
- LIVTENCITY (Drug) $162.54
- Epclusa (Drug) $150.79
- THERASPHERE-BIO (Device) $124.47
- OPDIVO (Biological) $93.09
- REZDIFFRA (Drug) $73.46
- Vemlidy (Drug) $41.92
- Envarsus XR (Drug) $34.60
- KEYTRUDA (Biological) $28.00
- OCA (Drug) $26.54
- MAVYRET (Drug) $22.29
- FERAHEME (Drug) $21.40
- Stivarga (Drug) $20.13
- Cimzia (Drug) $18.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in La Jolla
Dr. Matthew Schultzel, D.o, D.O
Surgery — Payments: $75,161
Surgery $75,161
Dr. Jason Sicklick, M.d, M.D
Surgery — Payments: $61,734
Surgery $61,734
Pascal Bortz, M.d, M.D
Surgery — Payments: $60,673
Surgery $60,673
Dr. Sunil Bhoyrul, M.d, M.D
Surgery — Payments: $47,604
Surgery $47,604
Dr. Amy Lightner, Md, MD
Surgery — Payments: $42,964
Surgery $42,964
Dr. Mark Takata, Md, MD
Surgery — Payments: $38,605
Surgery $38,605